Back To The M&A Rumor Mill: Many Will Recall That Merck Owned These Women’s Health Businesses — After The Bust Up Of Schering Plough… Now To Be Sold, Again?

The saga of what is now Organon… travels through Schering-Plough, and then on to US Merck — and even through various rumors about Sanofi, more recently. As presently constituted, it is a women’s health set of franchises — primarily the implantable version of birth control.

Now come rumors that the massive Indian generics maker, Sun Pharma is quietly circling it. But at this point, these are strictly only… rumors.

We do know that as a public ’34 Act reporting company (spun out of Merck), Organon will soon have to disclose (at the SEC) — if it reaches an agreement on price and structure. This is at a size — a rumored $12 billion, more or less — that is plainly material. Here’s the rumor piece, from Yahoo Biz:

…Organon surged by 38.8 percent week-on-week, as investors gobbled up shares following reports that it is set to be acquired by Sun Pharmaceutical Industries for $12 billion.

According to a report by India-based The Economic Times, Sun Pharmaceutical submitted an offer to fully acquire Organon & Co., in an all-cash transaction. The two firms have yet to confirm or deny the reports….

The Dutch HQ-ed version of this biz was always very well run, but faced lots of deeply pocketed competitors… and eventually ended up getting sold and resold, by a series of private equity and Wall Street bankers. So it goes.

Onward, to a warm and broken-clouds Sunday, here. Smile.

नमस्ते